Risk for Epilepsy Reduced With GLP-1 Receptor Agonist Use in Type 2 Diabetes

MONDAY, Dec. 15, 2025-- For adults with type 2 diabetes mellitus (T2DM), glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy is associated with a reduced risk for epilepsy, according to a study published online Dec. 10 in...